Buprenorphine transdermal skin patch and Mogamulizumab-kpkc Intravenous
Determining the interaction of Buprenorphine transdermal skin patch and Mogamulizumab-kpkc Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine transdermal skin patch-Molindone
- Buprenorphine transdermal skin patch-Mometasone (Oral Inhalation)
- Buprenorphine transdermal skin patch-Mometasone and Formoterol
- Buprenorphine transdermal skin patch-Mometasone and formoterol Inhalation
- Buprenorphine transdermal skin patch-Mometasone Cream
- Buprenorphine transdermal skin patch-Mometasone Furoate
- Mogamulizumab-kpkc Intravenous-Buprenorphine, Buprenorphine Hydrochloride
- Mogamulizumab-kpkc Intravenous-Buprenorphine/naloxone Oromucosal, Sublingual
- Mogamulizumab-kpkc Intravenous-Buproban
- Mogamulizumab-kpkc Intravenous-Bupropion
- Mogamulizumab-kpkc Intravenous-Bupropion and naltrexone
- Mogamulizumab-kpkc Intravenous-Bupropion Extended-Release Tablets